Davis Polk advised the managers of the Rule 144A/Regulation S offering by NXP B.V. and NXP Funding LLC of $600 million principal amount of 4.125% senior notes due 2020 and $400 million…
Davis Polk advised the global coordinators in connection with a Rule 144A/Regulation S offering of $1.6 billion aggregate principal amount of 6.50% senior notes due 2022 by XPO Logistics,…
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A/Regulation S offering by TTX Company of $300 million aggregate principal amount of its 2.6%…
Davis Polk advised the joint book-running managers in connection with a $750 million SEC-registered offering by Autodesk, Inc., consisting of $450 million aggregate principal amount of 3…
Davis Polk advised the initial purchasers in connection with the Rule 144A/Regulation S offering by the Government of the Democratic Socialist Republic of Sri Lanka of US$650 million…
Davis Polk is advising Bio-Reference Laboratories, Inc. in connection with its approximately $1.47 billion acquisition by OPKO Health, Inc. Under the terms of the agreement, holders of Bio…
Davis Polk advised the several underwriters in connection with an SEC-registered offering by Atlas Air Worldwide Holdings, Inc. of $224.5 million aggregate principal amount of its 2.25%…
Davis Polk successfully represented Dialog Semiconductors in litigation related to the earnout provisions in its 2013 acquisition of iWatt. In April 2014, Fortis Advisors—acting on behalf…
Davis Polk advised the administrative agent, in connection with $1.6 billion senior secured credit facilities for Black Knight InfoServ, LLC, comprised of an $800 million term loan A…